NOELLE WANDS: Open Payments
NPI 1437731742 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 46 payments from 14 companies in 2025. Trend: 2023 $2,487 · 2024 $2,320 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $306 |
| ABBVIE INC. | 9 | $162 |
| Galderma Laboratories, L.P. | 4 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| UCB, Inc. | 3 | $93 |
| Lilly USA, LLC | 3 | $78 |
| PFIZER INC. | 3 | $70 |
| Incyte Corporation | 2 | $45 |
| Janssen Biotech, Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: Zoryve, SKYRIZI, NEMLUVIO, COSENTYX, Bimzelx, TALTZ, OPZELURA, CIBINQO.
Industry payments across CA — which companies pay providers there.
